Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Neuro-Oncology Advances|May 22, 2023
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2Justin T Jordan, Christina C Orr, Raquel D Thalheimer, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2025
AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1Edwina Abou Haidar, Shilpa Prabhakar, Alexandra L Geffrey, et al.
Human Mutation|May 19, 2018
Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findingsMeritxell Carrió, Bernat Gel, Ernest Terribas, et al.
Neurology|July 11, 2018
Cutaneous neurofibromas: Current clinical and pathologic issuesNicolas Ortonne, Pierre Wolkenstein, Jaishri O Blakeley, et al.
Cancer Research|April 9, 2009
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectorsHiroaki Wakimoto, Santosh Kesari, Christopher J Farrell, et al.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2022
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 27, 2026
Deciphering and Targeting the Schwannoma-Neuron-Macrophage Crosstalk for the Treatment of Schwannomatosis and Associated PainZhenzhen Yin, Limeng Wu, Yanling Zhang, et al.
Pageof 10